Abstract
Background Although ranges of normal respiratory rates (RR) have been described for children under five years old living in the tropics, there are few datasets recording rates in older children. The present study was designed to capture the changes in RR with age and to examine its association with nutritional status and environmental factors.
Methods A cohort of rural Gambian children aged from six months to 14 years had their RR recorded during home visits twice weekly during two annual rainy seasons. Measurements were made by trained field assistants using an electronic timer during a one-minute period. Age, sex, nutritional status, health status, time of day of data collection were recorded. A generalized additive model for location, scale and shape was used to construct the RR reference curves and a linear mixed effect model used to examine factors associated with RR. We also assessed the agreement between repeat measurements taken from a subset of study subject.
Results A total of 830 children provided 67,512 RR measurements. The median age was 6.07 years (interquartile range (IQR), 4.21–8.55) and 400 (48.2%) were female. The centile chart showed a marked nonlinear decline in RR measurements with increasing age up to six years old, after which the decline was minimal (predicted median RR of 31 breaths/minute (IQR: 29–34) among one-year-olds, 22 breaths/minute (IQR: 21–23) among six-year-olds and 21 breaths/minute (IQR: 21-22) among 13-year-olds. Age (non-linear effect, p<0.001), stunting (0.84 breaths/minute [95%CI: 0.40-1.28, p<0.001]), ambient temperature (0.38 breaths/minute [95%CI: 0.33-0.42, p<0.001] for every 1°C increase in ambient temperature) and time of day when RR measurements were taken (non-linear effect, p<0.001) were independent predictors of respiratory rate. Strikingly, children with signs of illness were associated with higher intra-observer variability.
Interpretation We constructed a RR reference chart for children aged one to 13 years and proposed a cutoff of >26 breaths/minute for raised RR among children aged >5 years bridging an important gap in this age group. Although time of data collection, nutritional status and ambient temperature were predictors of RR, the evidence is not clinically significant to warrant a change in the current WHO guidelines owing to the prevailing uncertainty in the measurement of RR. The finding that RR between repeat measurements were more variable among children with signs of illness suggests that a single RR measurements may be inadequate to reliably assess the status of sick children - a population in which accurate diagnosis is essential to enable targeted interventions with lifesaving treatment.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
lower%20incidence%20of%20clinical%20malaria.
Funding Statement
The study was funded by the MRC-DfID-Wellcome Trust (Global Health Trials MR/M007383/1). SWL is supported by the Global Challenges Research Fund’s BOVA Network (Global Challenges Research Fund (BB/R00532X/1) supported by the Biotechnology and Biological Sciences Research Council and Medical Research Council). JB received support from the UK Medical Research Council (MRC) and the UK Foreign, Commonwealth and Development Office (FCDO) under the MRC/FCDO Concordat agreement and is also part of the EDCTP2 programme supported by the European Union (Grant Ref: MR/R010161/1). Role of the funding source: The funders had no role in study design, data collection, data analysis, interpretation of results, writing of the manuscript or the decision to submit the manuscript for publication. The corresponding author had full access to the data and made the final decision to submit the manuscript for publication following written approval from the co-authors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the study was granted by The Gambia Government/Medical Research Council Joint Ethics Committee (reference: SCC 1390v3) and the School of Biological and Biomedical Sciences Ethics Committee, Durham University, Durham, UK (reference: SBBS/EC/ 1401/RooPfs).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Footnotes
↵† Joint First Authors.
Data Availability
Data sharing Access to clinical data requires a formal application to the Scientific Coordinating Committee of the Medical Research Council Unit The Gambia (MRCG) and the Joint Gambian Government’s and MRCG Ethics Committee in The Gambia at https://www.mrc.gm/scientific-coordinating-committee/
